TOP STORIES
respiratory
ILD

Pirfenidone may improve results for patients with non-IPF fibrotic ILDs: RELIEF


Pirfenidone yielded improved outcome over placebo in a trial of patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (IPF). However, though the results were significant, the trial was terminated early due to slow recruitment,...

Pirfenidone yielded improved outcome over placebo in a trial of patients with progressive fibrotic interstitial lung diseases other...

Read more